111 related articles for article (PubMed ID: 22426479)
1. Isolation of miRNAs that target EGFR mRNA in human lung cancer.
Yamaguchi G; Takanashi M; Tanaka M; Fujita K; Ohira T; Kuroda M; Ikeda N
Biochem Biophys Res Commun; 2012 Apr; 420(2):411-6. PubMed ID: 22426479
[TBL] [Abstract][Full Text] [Related]
2. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
3. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
Nymark P; Guled M; Borze I; Faisal A; Lahti L; Salmenkivi K; Kettunen E; Anttila S; Knuutila S
Genes Chromosomes Cancer; 2011 Aug; 50(8):585-97. PubMed ID: 21563230
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.
Zhu K; Ding H; Wang W; Liao Z; Fu Z; Hong Y; Zhou Y; Zhang CY; Chen X
Oncotarget; 2016 May; 7(19):28075-85. PubMed ID: 27057632
[TBL] [Abstract][Full Text] [Related]
7. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
[TBL] [Abstract][Full Text] [Related]
8. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
9. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
10. Exploring microRNA-mediated alteration of EGFR signaling pathway in non-small cell lung cancer using an mRNA:miRNA regression model supported by target prediction databases.
Wang F; Chan LW; Law HK; Cho WC; Tang P; Yu J; Shyu CR; Wong SC; Yip SP; Yung BY
Genomics; 2014 Dec; 104(6 Pt B):504-11. PubMed ID: 25257143
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
12. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G
Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802
[TBL] [Abstract][Full Text] [Related]
13. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
Brabender J; Danenberg KD; Metzger R; Schneider PM; Park J; Salonga D; Hölscher AH; Danenberg PV
Clin Cancer Res; 2001 Jul; 7(7):1850-5. PubMed ID: 11448895
[TBL] [Abstract][Full Text] [Related]
15. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
16. The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line.
Washio K; Aoe M; Toyooka S; Mushiake H; Tsukuda K; Shimizu N
Oncol Rep; 2003; 10(6):1967-71. PubMed ID: 14534727
[TBL] [Abstract][Full Text] [Related]
17. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
18. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.
Lee KM; Choi EJ; Kim IA
Radiother Oncol; 2011 Oct; 101(1):171-6. PubMed ID: 21676478
[TBL] [Abstract][Full Text] [Related]
19. Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR‑145 through the ERK1/2 in non-small cell lung cancer.
Guo YH; Zhang C; Shi J; Xu MH; Liu F; Yuan HH; Wang JY; Jiang B; Gao FH
Oncol Rep; 2014 Apr; 31(4):1940-6. PubMed ID: 24535036
[TBL] [Abstract][Full Text] [Related]
20. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
Qin Q; Wei F; Zhang J; Wang X; Li B
J Cell Mol Med; 2016 Oct; 20(10):1974-83. PubMed ID: 27241841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]